The Filing Desk

Carlsmed vs Shoulder Innovations

Carlsmed CARL · Shoulder Innovations SI · Health Care Equipment

Carlsmed reported revenue of $50 million in fiscal 2025, about the same as Shoulder Innovations' $47 million in fiscal 2025. Carlsmed's revenue grew 85.9% in its latest year, and Shoulder Innovations' grew 49.6%. Carlsmed had an operating margin of -60.5%, against -55.6% at Shoulder Innovations. Free cash flow was −$30 million at Carlsmed and −$36 million at Shoulder Innovations.

Side by side

CarlsmedShoulder Innovations
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$50M$47M
Revenue growth85.9%49.6%
Revenue growth a year, last 5 years——
Gross margin75.3%76.5%
Operating margin−60.5%−55.6%
Net margin−58.7%−85.3%
Free cash flow−$30M−$36M
Free cash flow margin−58.6%−76.1%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count249.7%13,340.5%
Last close$17.22$20.31
P/E at the last close——
Insider trades, last 12 monthssold $2.6 millionbought $214,878, sold $5.5 million
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
CarlsmedShoulder Innovations
Operating margin
Percent of revenue
CarlsmedShoulder Innovations
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CarlsmedShoulder Innovations

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Carlsmed and Shoulder Innovations pages.